List view / Grid view




Midatech Pharma awarded EU grant funding to support training and research into glycan based multivalent immunotherapeutics

17 December 2014 | By Midatech Pharma

Midatech Pharma, a nanomedicine company developing and commercialising multiple therapeutic products to enhance the delivery of medicines in major diseases with high unmet medical needs, is pleased to announce that a consortium of academic and industry groups including Midatech has been awarded a €3.8 million European Union grant...